Literature DB >> 6703061

Glomerulopathy does not increase renal susceptibility to acute ischemic injury.

R A Zager, L A Baltes, H M Sharma, W G Couser.   

Abstract

To determine whether preexistent glomerular injury and the nephrotic syndrome increase renal susceptibility to ischemic renal injury, normal rats and rats with either experimental minimal-change disease (Adriamycin nephropathy) (AN) or membranous nephropathy (passive Heymann nephritis) (PHN) underwent renal functional and histologic studies under either basal conditions or 18 h after bilateral renal artery occlusion (over 30 min). Prior to renal ischemia AN and PHN rats had minimally depressed glomerular filtration rate (GFR), normal (AN) or increased (PHN) renal blood flow (RBF), heavy proteinuria, hypoalbuminemia, decreased urine sodium excretion, extensive glomerular foot process fusion, and intratubular hyalin cast formation. Losses of GFR in response to ischemia were comparable among the three groups of rats (controls, 0.29; AN, 0.28; PHN, 0.25 ml X min-1 X 100 g body wt-1) despite prevailing differences in postischemic hemodynamics. Neither light nor transmission electron microscopy showed any differences in the degree of ischemic renal injury. These results suggest that 1) glomerulopathy and the nephrotic syndrome do not significantly increase renal susceptibility to ischemic renal injury; 2) the syndrome of acute renal failure that occurs in patients with minimal-change glomerulopathy is not due to a marked susceptibility of these kidneys to clinically occult ischemic events; and 3) foot process fusion is probably not a pathophysiologically significant lesion in ischemic acute renal failure, as previously suggested.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703061     DOI: 10.1152/ajprenal.1984.246.3.F272

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Glomerular inflammation induces resistance to tubular injury in the rat. A novel form of acquired, heme oxygenase-dependent resistance to renal injury.

Authors:  B A Vogt; T P Shanley; A Croatt; J Alam; K J Johnson; K A Nath
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Gentamicin and gram-negative bacteremia. A synergism for the development of experimental nephrotoxic acute renal failure.

Authors:  R A Zager; R B Prior
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

3.  Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression.

Authors:  Ali C M Johnson; Julie M Yabu; Sherry Hanson; Vallabh O Shah; Richard A Zager
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.